The CEO of Gilead Sciences says U.S. hospitals should get enough of its drug to fight COVID-19 to treat as many as 200,000 patients this week.
Coronavirus treatment drug remdesivir to arrive in hospitals this week, Gilead CEO says
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over